Skip to main content

Month: March 2025

Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain

Conference call and webcast at 8:00 a.m. ET on Monday, March 3, 2025 THE WOODLANDS, Texas, March 02, 2025 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will hold a conference call and webcast on Monday, March 3, 2025 at 8:00 a.m. ET to share topline results from the Phase 2b PROGRESS (A Phase 2b, Dose-ranging, Randomized, Double-blind, PlacebO-controlled, Parallel-GRoup, MulticEnter Study with an Open-label Extension in PatientS with Diabetic Peripheral Neuropathic Pain) study evaluating pilavapadin (LX9211), an oral, non-opioid investigational adaptor-associated kinase 1 (AAK1) inhibitor in adult patients with moderate to severe diabetic peripheral neuropathic pain (DPNP). Conference Call and Webcast InformationLexicon management will hold a live conference call and webcast on Monday,...

Continue reading

Initial Drill Results Prove Significant Polymetallic Mineralization at Mirasol’s Flagship Sobek Gold-Copper Project in the Vicuña District, Chile

Initial drilling of the Potro SE target on Sobek North intersected a new polymetallic mineralized system: 17.4m at 0.72g/t gold Eq. including 3.0m at 2.39 g/t gold Eq and high silver, lead, zinc with indications of copper The drill hole ended in strongly altered porphyritic rock and the system remains open laterally and at depth The mineralized intercept is directly associated with a large IP-PDP geophysical chargeability response which underlies a cylindrical magnetic susceptibility anomaly localized along a major structural corridor A second drill hole is currently in progress 200m to the east to test the core of the magnetic anomaly and confirm the continuity of mineralization Sobek Potro SE target is located 3 km southwest of NGEx’s Lunahuasi discovery in the Vicuña District, Chile At Sobek Central, the access road to reach the...

Continue reading

AMERICAN SALARS TO EXPAND ITS POCITOS PROJECT BY 1,635% TO 13,880 HECTARES IN ARGENTINA’S LITHIUM TRIANGLE

VANCOUVER, BC, March 02, 2025 (GLOBE NEWSWIRE) — AMERICAN SALARS LITHIUM INC. (“AMERICAN SALARS” OR THE “COMPANY”) (CSE: USLI, OTC: USLIF, FWB: Z3P, WKN: A3E2NY) announces it has entered into a Letter Of Intent Agreement (the “Agreement”) with an arm’s length vendor to acquire up to 100% of the Salar De Pocitos Project (the “Project”) consisting of 10 mineral tenements spanning approximately 13,080 hectares and contiguous to the Company’s 800 hectare Flagship Pocitos 1 Project in Salta Province, Argentina. This represents a property size increase of 1635% to a footprint combined total of 13,880 hectares on the Pocitos Salar, within the prolific Lithium Triangle. The closing of this transaction will culminate in American Salars having the second largest property asset on the Salar de Pocitos.The Company’s...

Continue reading

Latin Metals Identifies Geophysical Anomalies at Cerro Bayo, Santa Cruz, Argentina

VANCOUVER, British Columbia, March 02, 2025 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) (OTCQB: LMSQF) is pleased to announce the identification of significant geophysical anomalies at its Cerro Bayo project (“Cerro Bayo” or the “Project”), located in the Deseado Massif, Santa Cruz Province, Argentina. The Company has completed purchase of historical exploration data collected by a previous operator at the project, including a 130-line-km gradient array Induced Polarization (“IP”) geophysical survey. The survey highlights pronounced chargeability and resistivity anomalies, spatially associated with historical drill targets identified by Barrick, and there is a strong correlation of chargeability anomalies with previously mapped mineralized structures. Importantly the anomalous geophysical...

Continue reading

Nokia and industry partners accelerate AI-RAN development #MWC25

Press ReleaseNokia and industry partners accelerate AI-RAN development #MWC25 Nokia’s ecosystem of industry partnerships is driving advancements in AI-RAN architecture and the deployment and optimization of AI-powered Radio Access Networks. Collaboration helps lay the foundations for platform-as-a-service business models for operators offering scalable computing infrastructure and capabilities for AI and other services in addition to connectivity. Nokia opens AI-RAN Center in Dallas, U.S to accelerate development of AI-RAN with partners. AI-RAN will have a transformative impact on the future of telecommunications infrastructure and services.2 March 2025Espoo, Finland – At Mobile World Congress 2025, Nokia and its ecosystem of industry partners, KDDI, SoftBank Corp., T-Mobile US, and NVIDIA today outlined the advances made in the...

Continue reading

Ellomay Capital Announces Execution of Project Finance Agreements for its 198 MW Solar Portfolio in Italy

Tel-Aviv, Israel, March 02, 2025 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today reported that its wholly-owned subsidiary, Ellomay Holdings Luxembourg Sarl (“Ellomay Luxembourg”), which owns a portfolio of 198 MW solar facilities in Italy, among other assets, that includes operating and “ready to build” projects (the “Italian Solar Portfolio”), entered into a set of agreements governing the procurement of financing (the “Project Finance”) with a reputable European institutional investor (the “Lender”), intended to finance the construction and related expenses of the Italian Solar Portfolio. The Italian Solar Portfolio includes three solar facilities,...

Continue reading

TransPerfect Acquires Technicolor Games

Leading Gaming Studio to Become Division of TransPerfect Gaming SAN FRANCISCO and BANGALORE, India, March 01, 2025 (GLOBE NEWSWIRE) — TransPerfect, the world’s largest provider of language and AI solutions for global business, today announced it has acquired Technicolor Games, the gaming division of Technicolor Group, S.A. Financial terms of the transaction were not disclosed. With offices in London, San Francisco, Montreal, and Bangalore, Technicolor Games includes more than 400 creative artists specializing in concept art, 3D art, animation, VFX, and cinematics. The company works with a global clientele—including major developers like Electronic Arts, Capcom, and 2K—on AAA titles such as Dragon Age: The Veilguard, Hogwarts Legacy, FC25, and Street Fighter 6. As part of the deal, TransPerfect will welcome all Technicolor Games...

Continue reading

Notification of transaction by an Officer of Millicom (Tigo)

Notification of transaction by an Officer of Millicom (Tigo)  Luxembourg, March 1, 2025 – Millicom International Cellular S.A. (“Millicom” or the “Company”) announces that, on February 27, 2025, under an existing 10b5-1 plan, Mr. Salvador Escalon, Chief Legal and Compliance Officer, sold 10,991 Millicom shares in the open market at an average price of $28.8473 per share. As a result, Salvador Escalon currently owns 151,410 shares. Details of the transaction are recorded on the personal trading section of Millicom’s website.  For further information, please contact:Press: Sofía Corral, Director Corporate Communications press@millicom.com Investors: Michel Morin, VP Investor Relations investors@millicom.com About Millicom Millicom (NASDAQ U.S.: TIGO, Nasdaq Stockholm: TIGO_SDB) is a leading provider of...

Continue reading

Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

REDWOOD CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, is presenting updated clinical data from the Phase 1b/2a BEACON study, as well as data from four preclinical studies evaluating briquilimab, at the AAAAI 2025 Annual Meeting, being held February 28 – March 3, 2025, in San Diego, CA. The BEACON update, based on a data-cut date of January 31, 2025, features approximately one month of additional dosing and follow-up from the 49 participants covered in Jasper’s preliminary data disclosure on January 8, 2025. Briquilimab continues...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.